News from Guardant Health A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

24 May, 2017, 12:00 ET New York State Issues Approval for the Guardant360 Assay

Guardant Health announced that the Guardant360® assay has been approved by New York State's Clinical Laboratory Evaluation Program (CLEP). The...


18 May, 2017, 09:00 ET Guardant Health Announces Draft Medicare Local Coverage Determination for the Guardant360 Assay

Guardant Health® announced that Palmetto GBA, a Medicare Administrative Contractor and leader in evaluating molecular diagnostic technology through...


11 May, 2017, 08:00 ET Guardant Health Partners with SoftBank to Accelerate Efforts in Early Cancer Detection

Guardant Health, the world leader in comprehensive liquid biopsies, announced an ambitious goal to sequence the tumor DNA of more than 1 million...


31 Jan, 2017, 09:12 ET MD Anderson and Guardant Health announce partnership to make comprehensive liquid biopsy part of oncology standard of care

The University of Texas MD Anderson Cancer Center and Guardant Health today announced a multi-year partnership designed to accelerate comprehensive...


06 Jan, 2017, 09:01 ET Guardant Health to create a new 500-plus-gene liquid biopsy panel with several leading pharmaceutical companies to accelerate clinical trials and drug development

Guardant Health today announced that it has entered into separate agreements with AstraZeneca, Merck (known as MSD outside the United States and...


06 Jan, 2017, 09:01 ET Ian Clark joins Guardant Health Board of Directors

Guardant Health Inc., the creator of the gold standard for comprehensive liquid biopsy, announced that Ian Clark has joined its board of directors....


16 Nov, 2016, 09:00 ET Guardant Health Announces Milestone Partnership with Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Guardant Health Inc. announced today a comprehensive partnership with Northwestern University that will make Guardant360 the preferred liquid...


03 Nov, 2016, 09:01 ET Guardant Health Announces Enhancements to Guardant360 Designed to Further Improve Clinical Sensitivity and Utility

Guardant Health announced enhancements to Guardant360, the gold standard for comprehensive liquid biopsy, to help oncologists provide the best...


17 Oct, 2016, 11:01 ET Guardant Health makes commitment to share expertise and data to advance Blood Profiling Atlas, part of White House Cancer Moonshot

Guardant Health announced today that it will contribute data from 500 advanced lung-cancer patients tested with Guardant360 to the Blood Profiling...


09 Sep, 2016, 10:05 ET Prospective, independent study demonstrates the utility of Guardant360 for guiding therapy selection in advanced Non-Small-Cell Lung Cancer

 A new prospective study of Guardant360® was published in Clinical Cancer Research, adding to the growing body of evidence demonstrating...


14 Jul, 2016, 09:00 ET Guardant Health Collaborates with OncoMed Pharmaceuticals on Anti-RSPO3 Clinical Trial

 Guardant Health, the leader in comprehensive liquid biopsies, announced a strategic collaboration with OncoMed Pharmaceuticals, a...


07 Jul, 2016, 09:00 ET Priority Health becomes first health plan to cover Guardant Health's comprehensive liquid biopsy, Guardant360®

 Guardant Health announced an agreement with Priority Health, one of Michigan's largest health plans, that will bring its comprehensive liquid...


06 Jun, 2016, 07:30 ET First prospective clinical utility trial using comprehensive liquid biopsy to guide metastatic cancer patients to molecularly matched therapies demonstrates comparable results to tissue-based testing

Guardant Health and Samsung Medical Center (Sungkyunkwan University School of Medicine, Korea) announced today the results of the first prospective...


07 Jan, 2016, 07:30 ET Guardant Health Secures Series D Financing to Expand the Reach of its Digital Sequencing™ Platform in Oncology

 Guardant Health, the leader in non-invasive cancer genomic sequencing, today announced it has completed a first closing on the majority of a...


02 Dec, 2015, 06:00 ET Guardant Health and Labco Quality Diagnostics (synlab Group) Announce Joint International Expansion

 Guardant Health, the leader in liquid biopsies, announced today that will accelerate the international commercialization of its...


09 Nov, 2015, 07:00 ET Guardant Health® and Collaborators Present Further Clinical Utility Data for Guardant360® at the AACR-NCI-EORTC International Conference On Molecular Targets and Cancer Therapeutics

 Guardant Health®, the leader in liquid biopsies, announced today the presentation of eight scientific posters by collaborators from...


20 Oct, 2015, 12:00 ET New studies show the power of comprehensive, non-invasive solid-tumor genomic testing with Guardant360®

 Guardant Health®, the leader in liquid biopsies, announced the publication of two peer-reviewed studies demonstrating the superior...


03 Sep, 2015, 09:00 ET Leading Cancer Centers to Present Clinical Utility Data For Guardant360 At IASLC's 16th World Conference on Lung Cancer in Denver Sept. 6-9

 Guardant Health®, the leader in liquid biopsies, announced today that five abstracts highlighting the performance and clinical utility of...


03 Feb, 2015, 06:00 ET Guardant Health Secures Additional $50 Million Based On Strong Demand For Its Biopsy-Free Cancer Blood Test, Guardant360®

 Guardant Health today announced the completion of its Series C financing for approximately $50 million, bringing the Company's total funding...


15 Sep, 2014, 08:30 ET Guardant Health Receives Accreditation from the College of American Pathologists

 Guardant Health, a healthcare company focused on the development and commercialization of oncology diagnostic products, today announced that...


08 Sep, 2014, 08:30 ET Guardant Health Appoints Richard Lanman, M.D. as Chief Medical Officer

Guardant Health, a healthcare company focused on the development and commercialization of non-invasive tumor sequencing tests, today announced that...


26 Aug, 2014, 08:00 ET Guardant Health Named a 2015 Technology Pioneer by World Economic Forum

 Guardant Health, a healthcare company focused on the development and commercialization of oncology diagnostic products, has been recognized...


08 Aug, 2014, 05:30 ET Guardant Health to Present at the WedBush 2014 Life Sciences Management Access Conference

 Guardant Health, a life sciences company focused on the development and commercialization of oncology diagnostic products, announced today...


30 May, 2014, 08:00 ET Guardant Health Announces US Commercial Launch of Guardant360™: A Breakthrough Blood Test for Real-Time Cancer Patient Treatment Management

 Guardant Health, a healthcare company focused on the development and commercialization of oncology diagnostic products, announced today that...


12 Feb, 2014, 16:30 ET Guardant Health Releases Breakthrough Blood Test to Improve Cancer Treatment

 Guardant Health TM today announced the commercial availability of GUARDANT360TM, the first pan-cancer blood test that helps oncologists...